Literature DB >> 3244198

Frequency- and voltage-dependent depression of maximum upstroke velocity of action potentials by pirmenol in guinea pig ventricular muscles.

H Nakaya1, N Tohse, M Kanno.   

Abstract

The frequency-dependency and voltage-dependency of the suppressing effect of pirmenol, a novel antiarrhythmic agent, on the maximum upstroke velocity (Vmax) of action potentials were examined and compared with those of disopyramide in guinea pig papillary muscles. Pirmenol in concentrations higher than 3 microM decreased Vmax with a slight increase in action potential duration. The reduction of Vmax by pirmenol was enhanced in a frequency-dependent manner over the range of 0.1-2.0 Hz. Pirmenol (30 microM) produced a small resting block (5.5%), whereas disopyramide (100 microM) produced a greater one (25.8%). The onset of frequency-dependent Vmax reduction at 2.0 Hz followed a monoexponential function with a slow rate constant (0.308 +/- 0.055 AP-1). The time constant for the recovery from the frequency-dependent block by pirmenol was also slow (33.5 +/- 5.4 sec), but faster than that of disopyramide (82.5 +/- 12.3 sec). At 1.0 Hz, pirmenol caused a shift (9.5 mV) of the curve relating the resting membrane potential and Vmax along the voltage axis in the hyperpolarizing direction. Thus, pirmenol is a Class Ia drug that has frequency- and voltage-dependent inhibitory actions on Vmax, and its onset and offset kinetics are relatively slow.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244198     DOI: 10.1254/jjp.48.423

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.

Authors:  J Hasegawa; S Hirai; N Noguchi; I Hisatome; H Kotake; H Mashiba
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.